Pemetrexed-induced Interstitial Lung Disease Mimicking Hypersensitivity Pneumonia: A Pathologically Proven Case

We herein report a 45-year-old woman with lung adenocarcinoma stage IV (cT4N3M1a). She was treated with pemetrexed (PEM) monotherapy following four cycles of first-line treatment with carboplatin, paclitaxel, and veliparib. After three cycles of PEM treatment, she presented with dyspnea, and chest c...

Descripción completa

Detalles Bibliográficos
Autores principales: Otoshi, Ryota, Sekine, Akimasa, Hagiwara, Eri, Okudela, Koji, Katano, Takuma, Aiko, Naoto, Matama, Goshi, Isomoto, Kohsuke, Ikeda, Satoshi, Baba, Tomohisa, Komatsu, Shigeru, Ogura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794179/
https://www.ncbi.nlm.nih.gov/pubmed/31178492
http://dx.doi.org/10.2169/internalmedicine.2548-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794179/
https://www.ncbi.nlm.nih.gov/pubmed/31178492
http://dx.doi.org/10.2169/internalmedicine.2548-18

Ejemplares similares